New Horizons in The Treatment of Pulmonary Fibrosis

Evening Symposium
Chairs: A. Wells London (United Kingdom)
Aims: Organised by Boehringer Ingelheim International GmbH
Welcome and introduction
A. Wells (London, United Kingdom)
Webcast
Webcast
The pathogenesis of IPF: what is the latest paradigm?
P. Sime (Rochester, United States of America)
Webcast
Webcast
Splitting: the road to precision medicine in IPF?
E. White (Ann Arbor, United States of America)
Webcast
Webcast
Questions and answers

No content made available
No content made available
Lumping: are the commonalities among fibrosing ILDs more important than the differences?
V. Cottin (Lyon, France)
Webcast
Webcast
How should we approach the treatment of progressive fibrosing ILDs?
K. Brown (Denver, United States of America)
Webcast
Webcast
SSc-ILD: are we entering a new chapter in treatment?
T. Maher (St. Albans, United Kingdom)
Webcast
Webcast
Questions and answers

No content made available
No content made available
Summary and close
A. Wells (London, United Kingdom)
No content made available
No content made available